Navigation Links
Harrisvaccines Awarded National Institute of Food and Agriculture Grant for Swine Disease Research
Date:10/1/2013

AMES, Iowa, Oct. 1, 2013 /PRNewswire/ -- Ames, Iowa-based vaccine producer, Harrisvaccines, today announced it has been awarded a grant from the USDA National Institute of Food and Agriculture (NIFA) for Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) research. This project is supported by Agriculture and Food Research Initiative Grant no. 2013-67015-21307 from the USDA National Institute of Food and Agriculture.

The grant, titled Proteomics-defined Porcine Reproductive and Respiratory Syndrome Virus Immunoproteome, will be a two-year project, beginning on October 1, 2013. Dr. Mark Mogler, Head of Research for Harrisvaccines, and Dr. Kurt Kamrud collaborated in achieving the grant with Dr. Manohar John of PathoVacs. Dr. Mogler will be serving as Project Director.

The basic research project will focus on a new way of looking for protective determinants of the PRRS virus. Harrisvaccines will be generating protein fragment libraries of PRRSV strains and the PRRSV protein fragment libraries will be screened using innovative technology developed by their collaborator on the project, Dr. John.

"Dr. John has a novel technology that allows him to screen thousands of antigens at a time," said Dr. Mogler. "This will be very beneficial, because rather than looking at only one antigen at a time, we will be able to look at tens of thousands simultaneously."

During the first year of the project, Harrisvaccines will be generating the fragments and creating fragment libraries for screening; screening will also be done during the first year. The second year of the project will mainly consist of data analysis and confirmatory testing.

At the end of the two years, Dr. Mogler is confident that Harrisvaccines will be able to characterize the immune response to PRRSV proteins by identifying reactive sites that otherwise, would not have been found.

"Ideally we would find a sequence, or a set of sequences, that are found across all PRRSV strains. We could then use these to make a more effective PRRSV vaccine," Dr. Mogler explained.

About Harrisvaccines

Headquartered in Ames, Iowa, Harrisvaccines focuses on revolutionizing animal health vaccines and enhancing productivity in the swine, cattle, equine, and farmed aquaculture industries. Using state-of-the-art advanced molecular science, Harrisvaccines employs their unique SirraVax(SM) RNA Particle (RP) technology platform to develop rapid-response, herd-specific products for animal diseases. To learn more about Harrisvaccines, visit www.harrisvaccines.com.

About PathoVacs

PathoVacs Incorporated is an early stage Biotechnology Company based in Ames, IA. The Company is based on a highly innovative proteome mining platform for novel protein antigen discovery for development of broadly protective/universal subunit vaccines against infectious agents that cause diseases in humans, livestock and poultry.  


'/>"/>
SOURCE Harrisvaccines
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Lpath Awarded NIH SBIR Grant for Lpathomab
2. Rudolf Kingslake Medal Awarded by SPIE for TNO Paper on Color Image Fusion for Night-Vision Applications
3. Genia Technologies, Columbia University, and Harvard University Awarded $5.25 Million Grant from NIH to Accelerate the Development of NanoTag DNA Sequencing Technology
4. Rhythm Awarded $1.35 Million from The Michael J. Fox Foundation to Advance Clinical Development of RM-131 for Refractory Constipation in Parkinsons Disease
5. VolitionRx-led Consortium Awarded euro 780 000 ($1M approx.) Eurostars Grant
6. Fumio Hirakawa has been awarded with the notable Golden A' Design Award
7. Curemark Awarded New Patent For Treatment Of Drug And Alcohol Addiction
8. VG Energy Chief Scientist Awarded $200,000 AgriLife Grant to Study Lipid Secretion
9. Boehringer Laboratories LLC Awarded HPG Contract for Clinical Suction Regulators
10. ConfometRx Awarded Patent on GPCRs that Contain a Stabilizing IC2 Fusion Protein
11. Puritan Awarded New Canadian Patent for PurFlock® Ultra Flocked Swab
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... ... Spyker, PhD, MD former Acting Deputy Director in the FDA CDRH Division of ... Staff has joined the company as an Expert Consultant. , In Dr. Spyker’s ...
(Date:2/21/2017)... , Feb. 21, 2017 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or ... operational results for the three months ended December 31, 2016. ... -based life sciences and diagnostics company that develops and commercializes ... ... to build on the commercial milestones achieved in fiscal 2016," ...
(Date:2/21/2017)... ... February 21, 2017 , ... The medical potential of stem cells is both ... of medicine, due to their differentiating characteristics. Stem cells are unique as the have ... be induced to become tissue or organic-specific cells with special functions. , Stem ...
(Date:2/21/2017)... 2017  Lexus, a returning partner of the Amgen Tour ... exclusive automobile partner of the men,s and women,s events for the ... 2017 Amgen Tour of California will mark ... the best professional cycling teams in the world racing from Northern ... Amgen Breakaway from Heart Disease TM Women,s Race ...
Breaking Biology Technology:
(Date:2/3/2017)... , Feb. 3, 2017 A new independent ... Strategy Partners, LLP (IdSP) . Designed to fill a ... complex identity market, founding partners Mark Crego ... combined years just in identity expertise that span federal ... non-profit leadership. The Crego-Kephart combined expertise has a common ...
(Date:1/31/2017)... 2017  Spero Therapeutics, LLC, a biopharmaceutical company ... of bacterial infections, today announced it has acquired ... Pro Bono Bio Ltd (PBB) to bolster its ... forms of Gram-negative bacteria.   The assets acquired have ... PBB group company. "The acquisition of ...
(Date:1/24/2017)... Jan. 24, 2017 Biopharm Reports has ... laboratory use of nuclear magnetic resonance spectroscopy (NMR). ... and profiled current practices, developments, trends and end-user ... as growth and opportunities. These areas include growth ... instruments, needs and innovation requirements, hyphenated NMR techniques, ...
Breaking Biology News(10 mins):